Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


22.05.2017

1 Am J Epidemiol
1 Arch Virol
1 Blood
1 Cancer
3 Clin Infect Dis
2 Dig Dis Sci
1 Hepatology
2 Int J Cancer
2 J Med Virol
3 J Viral Hepat
3 J Virol
1 JAMA
2 Lancet Gastroenterol Hepatol
1 MMWR Morb Mortal Wkly Rep
3 PLoS One
2 Proc Natl Acad Sci U S A
1 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Epidemiol

  1. HASSAN MA, Kim WR, Li R, Smith CI, et al
    Characteristics of US-Born Versus Foreign-Born Americans of African Descent With Chronic Hepatitis B.
    Am J Epidemiol. 2017 May 19:1-11. doi: 10.1093.
    PubMed     Text format     Abstract available


    Arch Virol

  2. CATTOIR L, Van Hoecke F, Van Maerken T, Nys E, et al
    Hepatitis E virus serology and PCR: does the methodology matter?
    Arch Virol. 2017 May 18. doi: 10.1007/s00705-017-3395.
    PubMed     Text format     Abstract available


    Blood

  3. DEL PADRE M, Todi L, Mitrevski M, Marrapodi R, et al
    Reversion of anergy signatures in clonal CD21low B cells of mixed cryoglobulinemia after clearance of HCV viremia.
    Blood. 2017 May 15. pii: blood-2017-03-771238. doi: 10.1182/blood-2017-03-771238
    PubMed     Text format     Abstract available


    Cancer

  4. HWANG JP, Suarez-Almazor ME, Cantor SB, Barbo A, et al
    Impact of the timing of hepatitis B virus identification and anti-hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapy.
    Cancer. 2017 May 18. doi: 10.1002/cncr.30729.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  5. MOON J, Hyland RH, Zhang F, Brainard DM, et al
    Efficacy and safety of ledipasvir/sofosbuvir for the treatment of chronic hepatitis C in persons with sickle cell disease.
    Clin Infect Dis. 2017 May 13. doi: 10.1093.
    PubMed     Text format     Abstract available

  6. BOSCHI C, Colson P, Tissot-Dupont H, Bernit E, et al
    Hepatitis C virus relapse 78 weeks after completion of successful direct acting therapy.
    Clin Infect Dis. 2017 May 16. doi: 10.1093.
    PubMed     Text format    

  7. ZUCMAN D, Farfour E, Mazaux L, Hillaire S, et al
    How to face the outbreak of viral hepatitis A in men-who-have-sex-with-men in France without vaccines?
    Clin Infect Dis. 2017 May 16. doi: 10.1093.
    PubMed     Text format    


    Dig Dis Sci

  8. LENCI I, Bosa A, Milana M, Baiocchi L, et al
    Evidence of Spontaneous Post-transplant HCV Eradication in Two Failed DAA Treatments Awaiting Liver Transplantation.
    Dig Dis Sci. 2017 May 12. doi: 10.1007/s10620-017-4594.
    PubMed     Text format    

  9. ROGAL SS, McCarthy R, Reid A, Rodriguez KL, et al
    Primary Care and Hepatology Provider-Perceived Barriers to and Facilitators of Hepatitis C Treatment Candidacy and Adherence.
    Dig Dis Sci. 2017 May 18. doi: 10.1007/s10620-017-4608.
    PubMed     Text format     Abstract available


    Hepatology

  10. SAXENA V, Khungar V, Verna EC, Levitsky J, et al
    Safety and Efficacy of Current DAA Regimens in Kidney and Liver Transplant Recipients with Hepatitis C: Results from the HCV-TARGET Study.
    Hepatology. 2017 May 15. doi: 10.1002/hep.29258.
    PubMed     Text format     Abstract available


    Int J Cancer

  11. MAKIUCHI T, Sobue T, Kitamura T, Ishihara J, et al
    The relationship between vegetable/fruit consumption and gallbladder/bile duct cancer: A population-based cohort study in Japan.
    Int J Cancer. 2017;140:1009-1019.
    PubMed     Text format     Abstract available

  12. CHU YJ, Yang HI, Wu HC, Liu J, et al
    Aflatoxin B1 exposure increases the risk of cirrhosis and hepatocellular carcinoma in chronic hepatitis B virus carriers.
    Int J Cancer. 2017 May 16. doi: 10.1002/ijc.30782.
    PubMed     Text format     Abstract available


    J Med Virol

  13. DOS SANTOS MIMA, Rugiere SP, Stocker A, Schinoni MI, et al
    Mutations Associated With Drug Resistance and Prevalence of Vaccine Escape Mutations In Patients With Chronic Hepatitis B Infection.
    J Med Virol. 2017 May 13. doi: 10.1002/jmv.24853.
    PubMed     Text format     Abstract available

  14. HUANG X, Ma C, Zhang Q, Shi Q, et al
    Impact of "a" Determinant Mutations on Detection of Hepatitis B Surface Antigen (HBsAg) in HBV Strains from Chinese Patients with Occult Hepatitis B.
    J Med Virol. 2017 May 17. doi: 10.1002/jmv.24859.
    PubMed     Text format     Abstract available


    J Viral Hepat

  15. OSIBOGUN O, Ogunmoroti O, Michos ED, Spatz ES, et al
    HIV/HCV Co-infection and the risk of Cardiovascular Disease: A Meta-analysis.
    J Viral Hepat. 2017 May 14. doi: 10.1111/jvh.12725.
    PubMed     Text format     Abstract available

  16. ROB B, Moreno C, Van Vlierberghe H, Bourgeois S, et al
    The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C infected patients treated with direct acting antivirals with and without Pegylated Interferon: A Belgian experience.
    J Viral Hepat. 2017 May 15. doi: 10.1111/jvh.12726.
    PubMed     Text format     Abstract available

  17. MCLEOD A, Cullen BL, Hutchinson SJ, Roy KM, et al
    Limited Impact of Awareness-Raising Campaigns on Hepatitis C Testing Practices among General Practitioners.
    J Viral Hepat. 2017 May 14. doi: 10.1111/jvh.12724.
    PubMed     Text format     Abstract available


    J Virol

  18. SYED GH, Khan M, Yang S, Siddiqui A, et al
    Hepatitis C virus lipoviroparticles (HCV-LVP) assemble in the endoplasmic reticulum (ER) and bud off from the ER to Golgi in COPII vesicles.
    J Virol. 2017 May 17. pii: JVI.00499-17. doi: 10.1128/JVI.00499.
    PubMed     Text format     Abstract available

  19. WALTER S, Rasche A, Moreira-Soto A, Pfaender S, et al
    Differential Infection Patterns and Recent Evolutionary Origins of Equine Hepaciviruses in Donkeys.
    J Virol. 2016;91.
    PubMed     Text format     Abstract available

  20. LOGAN M, Law J, Wong JA, Hockman D, et al
    Native folding of a recombinant gpE1/gpE2 heterodimer vaccine antigen from a precursor protein fused with Fc IgG.
    J Virol. 2016 Oct 19. pii: JVI.01552.
    PubMed     Text format     Abstract available


    JAMA

  21. VOELKER R
    A First in HCV Drugs for Youths.
    JAMA. 2017;317:1942.
    PubMed     Text format    


    Lancet Gastroenterol Hepatol

  22. BOURLIERE M
    Hepatitis B treatment: could we extend the current treatment indication?
    Lancet Gastroenterol Hepatol. 2017 May 15. pii: S2468-1253(17)30140.
    PubMed     Text format    

  23. DE NIET A, Jansen L, Stelma F, Willemse SB, et al
    Peg-interferon plus nucleotide analogue treatment versus no treatment in patients with chronic hepatitis B with a low viral load: a randomised controlled, open-label trial.
    Lancet Gastroenterol Hepatol. 2017 May 15. pii: S2468-1253(17)30083.
    PubMed     Text format     Abstract available


    MMWR Morb Mortal Wkly Rep

  24. ABARA WE, Cha S, Malik T, DeSimone MS, et al
    Hepatitis B Surface Antigen Screening Among Pregnant Women and Care of Infants of Hepatitis B Surface Antigen-Positive Mothers - Guam, 2014.
    MMWR Morb Mortal Wkly Rep. 2017;66:506-508.
    PubMed     Text format     Abstract available


    PLoS One

  25. BAEZ PA, Lopez MC, Duque-Jaramillo A, Pelaez D, et al
    First evidence of the Hepatitis E virus in environmental waters in Colombia.
    PLoS One. 2017;12:e0177525.
    PubMed     Text format     Abstract available

  26. D'ARMINIO MONFORTE A, Cozzi-Lepri A, Ceccherini-Silberstein F, De Luca A, et al
    Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort.
    PLoS One. 2017;12:e0177402.
    PubMed     Text format     Abstract available

  27. AGGARWAL R, Chen Q, Goel A, Seguy N, et al
    Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India.
    PLoS One. 2017;12:e0176503.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  28. PADMANABHAN P, Dixit NM
    Inhibitors of hepatitis C virus entry may be potent ingredients of optimal drug combinations.
    Proc Natl Acad Sci U S A. 2017 May 16. pii: 201704531.
    PubMed     Text format    

  29. OHASHI H, Koizumi Y, Fukano K, Wakita T, et al
    Reply to Padmanabhan and Dixit: Hepatitis C virus entry inhibitors for optimally boosting direct-acting antiviral-based treatments.
    Proc Natl Acad Sci U S A. 2017 May 16. pii: 201705234.
    PubMed     Text format    


    Transplantation

  30. BARBIER L, Cesaretti M, Dondero F, Cauchy F, et al
    Liver Transplantation With Older Donors: A Comparison With Younger Donors in a Context of Organ Shortage.
    Transplantation. 2016;100:2410-2415.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: